Algonomics Nets $2.7M After Second Closing of VC Round | GenomeWeb
NEW YORK (GenomeWeb News) — Algonomics has taken in €500,000 ($670,000) in a second closing of a financing round to net a total of €2 million ($2.7 million), the company said today.
The immunoprofiling company plans to use the funding to continue developing an in vitro screening platform, called Epibase, to complement its existing screening products and services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.